For the last decade, overdose has been a leading cause of pregnancy-associated death in Colorado. Colorado providers have a unique opportunity to aid persons struggling with opioid use disorder (OUD) during the vulnerable perinatal period.
There is a shortage of providers in Colorado who are able to prescribe buprenorphine treatment for patients with OUD, and even fewer trained to care for the perinatal population. Buprenorphine can be prescribed during routine clinical care, including primary care, family practice, psychiatry, and the emergency department, to treat individuals with prescription opioid or heroin addiction, including during pregnancy and postpartum. With the increasing prevalence of maternal OUD and overdose deaths in the state, it is imperative that we increase treatment resources for these patients.
Due to this need, the Practice Innovations in Opioid Management at the CU Department of Family Medicine is able to offer a stipend for Colorado providers who invest the time to take the waiver training to get their DEA X waiver.
Those who complete a waiver training course and receive their waivers from DEA by September 30 will be eligible to receive up to $1000 in compensation.
To help educate providers like you about this exciting opportunity, we are holding two optional informational sessions. Register today or click here for more information about buprenorphine waiver training and education options.